Regulus Therapeutics
RGLS
#6949
Rank
C$0.78 B
Marketcap
C$11.27
Share price
0.00%
Change (1 day)
428.94%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: C$0.78 Billion

As of December 2025 Regulus Therapeutics has a market cap of C$0.78 Billion. This makes Regulus Therapeutics the world's 6949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025C$0.78 B439.2%
2024C$0.14 B321.6%
2023C$34.33 M9.67%
2022C$31.3 M-46.58%
2021C$58.59 M-46.39%
2020C$0.10 B347.42%
2019C$24.43 M118.57%
2018C$11.17 M-91.78%
2017C$0.13 B-15.06%
2016C$0.16 B-74.88%
2015C$0.63 B-30.07%
2014C$0.91 B177.15%
2013C$0.32 B46.44%
2012C$0.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
C$134.99 B 17,196.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
C$167.02 B 21,299.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$36.74 B 4,607.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$386.28 B 49,392.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
C$83.61 B 10,613.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.23 B-70.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$146.66 B 18,691.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
C$4.11 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA